Fin Cascade

Prices as of 8 Oct 2026 close · Not investment advice

Honasa Consumer Limited

NSE: HONASAPersonal Care

Share price

₹467.50

-2.00% close of 8 Oct 2026

Market cap ₹15,194 CrP/E 60.3

Business score

How strong the business is, in one number. The parts behind it are in Pro.

66

out of 100 · worked out 8 Oct 2026

Your ratios

The numbers you want to see first. Tap Edit to change them.

Market cap

₹15,194 Cr

P/E ratio

60.3

P/B ratio

10.8

ROCE

19.2%

ROE

15.7%

Dividend yield

0.6%

Price & valuation chart

How the share price and its valuation have moved. Hover over the chart to see any day. Prices as of the last close.

Prices as of 8 Oct 2026 close52-week high ₹502.8052-week low ₹256.30

Answers

Simple answers to the questions investors ask most, from the company's own numbers.

How fast it has been growing

Sales grew 21.1% over the past year, and 14.4% a year over its longer record. Meanwhile what it keeps of every 100 rupees of sales improved from 3.8% to 11.5% over the last three years.

Whether it grew faster than its sector

It grew 14.4% a year against a sector median of 9.9% — 4.5 percentage points faster.

Room to re-rate, or risk of de-rating

Too little price history yet to compare it with its own past.

Whether growth justifies the valuation

Priced at 0.5 times its growth rate, on earnings growth of 118%.

Profit growthPrice per ₹1 profitPer 1% growth
Honasa Consumer Limited — this one118%/yr60.3×—
Godrej Consumer Products5%/yr42.5×₹8.5
Dabur India4%/yr33.6×₹8.4
Cupid Limited—348.8×—
Colgate-Palmolive India8%/yr34.8×₹4.3
Gillette India Limited31%/yr35.9×₹1.2

Compared with companies filed under the same label. That grouping comes from the exchange's filing category, so some of them may not be real rivals.

How it compares with its peers

Against companies the exchange files under the same label (Personal Care), it ranks 8 of 10 on returns, 3 of 10 on growth, 9 of 10 on margin. That grouping comes from the exchange's filing category, so some of them may not be real rivals.

What makes it hard to beat — and is that still true?

No durable advantage shows in the numbers: it earns 19.2% on capital, ahead of 20% of companies filed under the same label. That grouping comes from the exchange's filing category, so some of them may not be real rivals.

Whether its growth pays for itself

Yes — Over the last five years it made ₹471 crore of cash from the business and spent ₹52 crore on plant and equipment, with ₹419 crore to spare; it still raised ₹735 crore from shareholders — borrowings did not rise. It has not made a profit over 6 years.

Profit reality check

Is the profit real cash? Simple checks on the accounts. Facts only, not advice.

8 of 9 checks clear · 89%

Latest result · Q1 FY27

What the last results showed. Whether management kept its word is in Pro.

Sales up 32% and the three-year sales-mix goal already reached in the first quarter

Announced 13 Aug 2026 · Consolidated · Unaudited

Revenue

₹756 Cr

Revenue vs last year

+27.0%

Revenue vs last quarter

+15.1%

Net profit

₹90 Cr

Profit vs last year

+120.6%

Profit vs last quarter

+31.1%

Net margin

12.0%

EPS

₹2.77

Earnings call transcript · 13 Aug 2026

Checklist before you investPRO

Points for and against, in one list.

Key numbers & peers

The main numbers grouped by topic, and how the company compares with similar ones.

Price

Market cap
₹15,194 Cr
Prev close
₹467.50
52w High
₹510
52w Low
₹248
Enterprise value
₹14,863 Cr
Beta
0.8
Price CAGR 1y
68.0%
Price CAGR 3y
—
Price CAGR 5y
—
Price CAGR 10y
—

Ratios

Return on assets
9.5%
PEG ratio
0.5
P/E ratio
60.3
P/B ratio
10.8
EV / EBITDA
49.5
Industry P/E
34.7
ROCE
19.2%
ROCE 5y average
10.2%
ROE
15.7%
Debt / Equity
0.1
Interest coverage
20.8
Dividend yield
0.6%
ROE 3y average
—
ROE last year
16.0%

Annual P&L

Annual revenue
₹2,392 Cr
Annual profit
₹200 Cr
Operating margin
10.0%
Net profit margin
8.4%
EBITDA margin
9.9%
Sales growth 3y
17.0%
Sales growth 5y
39.1%
Profit growth 3y
118.0%
Profit growth 5y
17.0%
EPS
₹6.2
Sales growth TTM
21.0%
Profit growth TTM
242.0%
Dividend payout
49.0%

Quarter P&L

Sales latest quarter
₹756 Cr
Profit latest quarter
₹90 Cr
YoY quarterly sales growth
27.0%
YoY quarterly profit growth
119.5%
OPM latest quarter
14.6%

Balance Sheet

Book Value
₹43.4
Face Value
₹10.0
Total debt
₹135 Cr
Total cash
₹214 Cr
Borrowings
₹135 Cr
Reserves / Equity
3.3

Cash Flow

Operating cash flow
₹141 Cr
Free cash flow
₹134 Cr
FCF yield
0.8%
Net cash flow
₹86 Cr

Shareholding

Promoter holding
35.5%
FII holding
13.6%
DII holding
21.6%
Public holding
29.3%

Peer comparison

CompanyPrice ₹P/EMkt cap ₹ CrDiv yield %Profit qtr ₹ CrProfit var %Sales qtr ₹ CrSales var %ROCE %
Godrej Consumer865.5542.788,5722.31504.510.64,225.515.418.8
Dabur India383.5534.368,0402.15586.215.03,764.410.620.3
Colgate-Palmoliv1,757.4034.947,7992.73343.17.81,603.311.8108.0
Cupid343.95336.646,2500.0044.2194.0157.0142.533.9
Gillette India7,223.5035.223,5412.49159.59.4783.010.890.7
P & G Hygiene6,921.0028.422,4663.32126.3-34.3891.5-4.9157.2
Emami375.4521.616,3882.66138.9-16.41,039.214.928.1
Honasa Consumer477.0561.615,5530.6390.5118.4756.027.019.2
Median454.5538.215,9710.3490.515.0756.015.430.2

Competes with: Colgate-Palmolive India, Cupid Limited, Dabur India, Emami Limited, Gillette India Limited, Godrej Consumer Products, Procter & Gamble Hygiene and Health Care Limited

Quarterly results

Sales and profit for each of the last 13 quarters. Newest on the right. ₹ crore.

Consolidated · to 30 Jun 2026
Line itemJun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Sales464496488471554462518534595538602657756
Expenses435456454438508493491507549490536580646
Material Cost000000
Change in Inventories210.790.7826-27-11
Purchases of Stock-in-Trade135171158164222240
Employee Cost486060717166
Other Expenses303318272276314350
Operating Profit2940343346-31262746486577110
OPM %6.318.117.067.038.32-6.655.055.067.698.86111215
Other Income1371119192019212420161923
Exceptional items (within Other Income)000-4.8000
Interest1233333333333
Depreciation6681091113121112111110
Profit before tax3439353952-24293256536782119
Tax %2725252223-2412222626251524
Net Profit2529263040-1926254139506990
EPS in Rs1.902.160.800.941.24-0.570.800.771.271.211.542.132.77
Diluted EPS in Rs0.771.261.201.542.122.76

Profit & loss

Yearly sales, costs and profit for 12 years, plus the last 12 months (TTM). ₹ crore.

Consolidated · to 31 Mar 2026
Line itemMar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales4609431,4931,9202,0672,3922,553
Expenses1,7949321,4701,7821,9972,1562,252
Material Cost00
Change in Inventories-43-0.23
Purchases of Stock-in-Trade656715
Employee Cost200263
Other Expenses1,1851,179
Operating Profit-1,334122313870236300
OPM %-2901.201.5073.401012
Other Income1221-13249777977
Exceptional items (within Other Income)0-4.80
Interest1379131313
Depreciation272531454444
Profit before tax-1,32522-14114790257321
Tax %1367251922
Net Profit-1,33214-15111173200249
EPS in Rs-13,06,09815,262-103.452.246.157.65
Diluted EPS in Rs2.236.12
Dividend Payout %0000049

Compounded growth

Average yearly growth over different spans, as stored. A span can cross a demerger or an acquisition.

Compounded sales growth

10 years
—
5 years
39%
3 years
17%
TTM
21%

Compounded profit growth

10 years
—
5 years
17%
3 years
118%
TTM
242%

Stock price CAGR

10 years
—
5 years
—
3 years
—
1 year
68%

Return on equity

10 years
—
5 years
—
3 years
—
Last year
16%

Balance sheet

What the company owns and what it owes, at the end of each year. ₹ crore.

Consolidated
Line itemMar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital0.010.01136324325325
Reserves-1,765-1,087-1,3237718551,086
Borrowings1,9541,8531,885131136135
Other Liabilities114271288413492560
Total Liabilities3031,0369861,6401,8082,107
Fixed Assets21342252299302489
CWIP020000
Investments164339260292305272
Other Assets1173544741,0491,2011,346
Total Assets3031,0369861,6321,7902,092

Cash flows

Real money coming in and going out each year — from the business, from investments and from loans. ₹ crore.

Consolidated
Line itemMar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Cash from Operating Activity3045-52235102141
Cash from Investing Activity-21-50540-470-145-17
Cash from Financing Activity-1481-14337-31-38
Net Cash Flow821-26102-7486
Free Cash Flow2942-6322482134

Ratios

How fast customers pay, how long stock sits, and how well capital earns — year by year.

Consolidated
Line itemMar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days272832302330
Inventory Days11486998310592
Days Payable221219161185212193
Cash Conversion Cycle-80-105-30-71-84-71
Working Capital Days-2-128-10-17-9
ROCE %5316819

Shareholding pattern

Who owns the company — founders (promoters), foreign funds, Indian funds and the public. In %.

Consolidated · to 30 Jun 2026
Line itemDec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Promoters3535353535353535363635
FIIs1012141915161616151414
DIIs1816171718181919191922
Public3737342831313030313129
No. of Shareholders53,18651,09544,82465,72494,58592,00881,09081,84182,09178,18785,336

Price trend

The price as a Renko brick chart: small moves drop out so the bigger path stands out.

Change over 1 year +62.3% (₹288.00 → ₹467.50)Brick size ₹19.24 (fixed)Bricks 16
₹300₹400₹500₹468Feb '26Jun '26
Price moved up one brickPrice moved down one brickLast close ₹467.50 on 8 Oct 2026

Every brick is the same size, about one typical day's move. A new brick needs a full brick's move; turning the other way needs two. Bricks show where the price went, not where it will go.

Open interestPRO

Where option traders are positioned on this stock.

Industry numbers

The numbers that matter most in this industry, from the company's own filings.

1 when an audit qualification is filed as repetitive

0.00flag

2026-03-31

the company's own unlisted debt securities in default at period end

0.00cr

2026-06-30

the company's own loans / revolving facilities in default at period end (standalone filing)

0.00cr

2026-06-30

net debt from the filed balance sheet at the newest year end: Borrowings − Cash Equivalents − Investments (Current); negative = net cash

-331inr_cr

2026-03-31

guarantees / comfort given for promoter, promoter group, directors and KMP

0.00cr

2026-03-31

loans outstanding to promoter, promoter group, directors and KMP (governance filing)

0.00cr

2026-03-31

security given for the borrowing of promoter, promoter group, directors and KMP

0.00cr

2026-03-31

volume growth %

30.50pct

2026-06-30

News

News and filings about Honasa Consumer Limited. Open one to see why it matters.

No recent news for this company.

Supply chain

Who it buys from, sells to and competes with — as recorded in our map of company links.

Uses as raw material

  • Plastic packaging material (crude-linked)
  • Surfactants (SLES/SLS, palm/petchem-derived)

Depends on the price of

  • Crude Oil Brent

Sells to

  • Amazon India · BPC finished goods via online marketplace
  • FSN E-Commerce Ventures Limited · Beauty & personal care finished goods (Mamaearth, The Derma Co.) sold via Nykaa marketplac…
  • Flipkart · BPC finished goods via online marketplace

Buys from

About

What the company is, from our own records: where it sits, where it makes things, and what it is made of.

Sector
Fast Moving Consumer Goods
Industry
Personal Care
Classification
Fast Moving Consumer Goods › Personal Care
ISIN
INE0J5401028

News impact

Big market events that reach Honasa Consumer Limited, and how the effect spreads.

29 Sept, 10:17 IST · Market event · high impact

Honasa Consumer Share Price Falls Over 3% On Block Deal Buzz

Early investors plan to sell up to 89 lakh Honasa shares in a block deal, so Honasa shares fell over 3%, hurting current holders while block buyers may get a discount and rivals see no change.

Fast Moving Consumer Goods

Who it hits first

  • Honasa Consumer, which sells Mamaearth beauty and baby-care products, fell over 3% after news that early backers may sell up to 89 lakh shares in one block trade.
  • Peak XV Partners, Sequoia Capital Global Growth Fund III and Redwood Trust are the likely sellers, cashing out part of their early stake.
  • A big sale like this adds many shares for sale at once, so the price dips until new buyers absorb the block.

Who may gain

  • Block-deal buyers, who may pick up Honasa shares at a discount to the market price
  • Short-term traders who sold early on the buzz and can buy back lower after the sale
  • Patient buyers who want Honasa for its brands and get a cheaper entry on the dip

Along the supply chain

Downstream

No downstream change — Nykaa, the beauty retailer that sells Honasa products, sees the same shopper demand; only Honasa's share price moves.

Upstream

No upstream change — software and order-service providers to Honasa see no order change when investors sell shares.

Where demand moves

Business

No change in shop demand — people buy the same Mamaearth creams and shampoos; only share ownership changes hands.

Capital

Selling pressure on Honasa shares — up to 89 lakh shares offered in the block must find new buyers, so the price slips until the block clears.

How it spreads across sectors

Fast Moving Consumer Goods

No real ripple — a single-company share sale does not change soap, cream or shampoo sales for Dabur, Godrej Consumer, Emami or Colgate.

When it plays out

Immediate

In 1-7 days, Honasa stays weak as the 89-lakh-share block hangs over the price and clears.

Medium term

In 1-6 months, price follows business — Mamaearth growth and profits matter, not the old investor exit.

Short term

In 1-4 weeks, shares steady once the block finds buyers and focus returns to sales and margins.

Who it hits first

  • HONASA: HONASA (Mamaearth): direct listed D2C beauty competitor faces sharper L'Oreal heat. PE 65.1 >> FMCG median 25.7 (premium); ROE 15.7 above 11.4; pledge 4.2%.

Who may gain

  • HINDUNILVR: HUL premium beauty validation. PE 33.5 above FMCG median 25.7; ROE 31.0 well above 11.4. Lakme/Dove portfolio benefits from category premiumisation.
  • DABUR: DABUR ayurvedic + beauty portfolio. PE 39.7 above FMCG median 25.7; ROE 17.2 above 11.4.
  • EMAMILTD: EMAMI premium personal care exposure. PE 25.0 at FMCG median 25.7; ROE 30.2 well above 11.4.

Along the supply chain

Downstream

NYKAA distribution channel benefits from Innovist brand growth; e-commerce volume growth; influencer/MarTech (AFFLE) benefits from increased beauty ad spend.

Upstream

Specialty chemicals (FINEORG, AARTIIND) and fragrance ingredient makers benefit from L'Oreal scaling Innovist with global supply chain.

Where demand moves

Business

L'Oreal majority in Innovist (Bare Anatomy) intensifies premium D2C beauty competition. HONASA Mamaearth faces direct pressure. NYKAA dual-edged: category growth positive, brand-side competition negative. Listed FMCG (HUL, DABUR, EMAMI) gain category premium validation.

Capital

Capital flows into premium beauty validation names — NYKAA, HONASA mixed; HUL premium-beauty exposure (Lakme, Dove, Pond) gets re-rating support. D2C-focused specialty chemicals (FINEORG, CLEAN) may see investor interest.

How it spreads across sectors

Beauty & Personal Care

M&A premium for D2C beauty assets

D2C

Exit liquidity validated — early-stage VCs see clearer exit pathway

FMCG

D2C premium beauty acquisition validates HUL, DABUR Vatika premium bet

codex additions

Commodity angle

Cc skip reason

no_commodity_link

When it plays out

Immediate

HONASA -3-5% on competitive intensity; NYKAA mixed (+/-1-2%); HUL, DABUR +1-2% sympathy.

Medium term

India premium beauty TAM doubles 2026-2028; consolidation cycle continues with more global PE/strategic interest.

Short term

Q1FY27 D2C beauty commentary will reveal L'Oreal-Innovist's pricing strategy — sustained re-rating or fade.

Other sectors it reaches

  • {"causal_chain":"Premium beauty consolidation raises demand for differentiated actives, surfactants, aroma chemicals, preservatives and formulation inputs as large strategics scale acquired D2C brands.","direction":"positive","example_tickers":["FINEORG","AARTIIND","CLEAN"],"magnitude":"medium","notes":"Benefit is indirect and depends on domestic sourcing versus imported formulations.","sector":"Specialty Chemicals \u0026 Fragrance Ingredients","time_horizon":"1_to_6_months"}
  • {"causal_chain":"Beauty and personal-care premiumization increases need for tubes, pumps, labels, cartons, rigid plastics and sustainable packaging as brands upgrade shelf appeal and omnichannel formats.","direction":"positive","example_tickers":["UFLEX","HUHTAMAKI","EPL"],"magnitude":"medium","notes":"EPL has direct relevance through laminated tubes used in oral care, beauty and personal care.","sector":"Packaging","time_horizon":"1_to_6_months"}
  • {"causal_chain":"Global FMCG buyers acquiring Indian D2C brands may outsource incremental production before investing in captive capacity, lifting demand for third-party formulation and manufacturing partners.","direction":"positive","example_tickers":["HINDUNILVR","GODREJCP","JYOTHYLAB"],"magnitude":"small","notes":"Few pure-play listed beauty contract manufacturers exist on NSE, so tickers are imperfect proxies through consumer manufacturing exposure.","sector":"Contract Manufacturing / CDMO for Consumer Products","time_horizon":"1_to_6_months"}
  • {"causal_chain":"Strategic validation of D2C beauty increases paid discovery, marketplace launches, brand-store investments and online assortment expansion across premium personal care.","direction":"positive","example_tickers":["NYKAA","INDIAMART","MSTCLTD"],"magnitude":"medium","notes":"NYKAA is mixed: competitive pressure from L'Oreal-controlled brands, but category traffic and GMV validation are supportive.","sector":"E-commerce Marketplaces \u0026 Online Retail Enablement","time_horizon":"immediate"}
  • {"causal_chain":"Beauty D2C brands rely heavily on influencer marketing, performance ads, CRM and content commerce; acquisition-driven competition can raise customer-acquisition spending across the category.","direction":"positive","example_tickers":["AFFLE","NAZARA","TIPSFILMS"],"magnitude":"small","notes":"Listed proxies are broad digital media/ad-tech plays rather than beauty-specific vendors.","sector":"Digital Advertising \u0026 MarTech","time_horizon":"1_to_4_weeks"}
  • {"causal_chain":"Premium beauty brands compete through creator-led education, celebrity collaborations, reels, tutorials and launch campaigns, increasing spend on digital content and influencer ecosystems.","direction":"positive","example_tickers":["SAREGAMA","TIPSINDLTD","ZEEL"],"magnitude":"small","notes":"Impact is diffuse and more visible in campaign activity than near-term earnings.","sector":"Media, Influencer \u0026 Entertainment Platforms","time_horizon":"1_to_4_weeks"}
  • {"causal_chain":"Scaling D2C beauty requires faster fulfillment, returns handling, marketplace warehousing and cold/controlled storage for certain formulations, supporting third-party logistics demand.","direction":"positive","example_tickers":["DELHIVERY","TCI","BLUEDART"],"magnitude":"small","notes":"Beauty is a small share of total logistics volumes, but high SKU complexity makes the category operationally relevant.","sector":"Logistics \u0026 Warehousing","time_horizon":"1_to_6_months"}
  • {"causal_chain":"D2C beauty brands that receive strategic backing often move from online-only to omnichannel kiosks, shop-in-shops and mall stores, lifting demand for premium retail space.","direction":"positive","example_tickers":["PHOENIXLTD","PRESTIGE","DLF"],"magnitude":"small","notes":"More relevant for premium malls and high-street retail than broad real estate.","sector":"Retail Real Estate / Malls","time_horizon":"1_to_6_months"}
  • {"causal_chain":"Large FMCG-led acquisitions validate consumer-brand M\u0026A, potentially increasing deal financing, advisory mandates, founder liquidity and wealth-management flows.","direction":"positive","example_tickers":["ICICIBANK","KOTAKBANK","AXISBANK"],"magnitude":"small","notes":"Likely modest unless it triggers a broader consumer D2C transaction cycle.","sector":"Private Banks \u0026 Investment Banking / Wealth","time_horizon":"1_to_6_months"}

Who it hits first

  • Honasa sees improved Q4, Goldman raises target

Who may gain

  • None directly

Along the supply chain

Downstream

N/A

Upstream

N/A

Where demand moves

Business

Mamaearth gaining D2C market share

Capital

Goldman endorsement attracts institutional flows into new-age consumer names

How it spreads across sectors

FMCG

D2C brands gaining share signals disruption risk for incumbents

When it plays out

Immediate

Stock rallies on Goldman target hike

Medium term

Path to sustainable profitability determines re-rating

Short term

Actual Q4 results needed

Who it hits first

  • Honasa Consumer reports strong Q4 growth

Who may gain

  • Honasa gains market share in D2C beauty

Along the supply chain

Downstream

None significant

Upstream

None significant

Where demand moves

Business

Consumer demand for natural beauty products growing

Capital

Growth stock momentum attracts retail flows

How it spreads across sectors

FMCG

Positive read for D2C brands

When it plays out

Immediate

Stock at 52-week high, 11% rally

Medium term

Profitability improvement needed to sustain valuation

Short term

Full Q4 results to confirm margins

Dividends, splits & big trades

Money paid out, share splits and buybacks, and big buys or sells by funds and insiders.

Dividends

28 Aug 2026unspecified₹3

Splits, bonuses & buybacks

  • daily-prices repair: 7 rows from NSE's archive (replace 2, delete 0, insert 5), 2023-11-12..2026-02-01 (docs/flat_day_repair.md)1× · 12 Nov 2023

Bulk & block deals

DateWhoBought / soldSharesPrice
29 Sep 2026PEAK XV PARTNERS INVESTMENTS VISELL1,07,55,495₹450.22
29 Sep 2026FRANKLIN TEMPLETON MUTUAL FUNDBUY33,33,333₹450.00
29 Sep 2026SEQUOIA CAPITAL GLOBAL GROWTH FUND III - U.S./ INDIA ANNEX FUND L.P.SELL25,02,289₹450.00
29 Sep 2026ICICI PRUDENTIAL LIFE INSURANCE COMPANY LIMITEDBUY17,77,777₹450.00
25 Jun 2026SOFINA VENTURES S.A.SELL41,78,384₹424.07
22 May 2026MICROCURVES TRADING PRIVATE LIMITEDBUY30,00,845₹392.12
22 May 2026MICROCURVES TRADING PRIVATE LIMITEDSELL30,00,845₹392.35
22 May 2026NK SECURITIES RESEARCH PRIVATE LIMITEDBUY27,87,698₹392.01
22 May 2026NK SECURITIES RESEARCH PRIVATE LIMITEDSELL27,87,698₹392.18
22 May 2026QE SECURITIES LLPBUY26,71,616₹393.70

Documents

Annual reports, results presentations and earnings calls, straight from the source.

Facts from company filings and exchange data. Not investment advice: nothing here tells you to buy or sell.